Related Experiment Video
Updated: Apr 11, 2026

07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
4.4K
Smartphone-Supported versus Full Behavioural Activation for Depression: A Randomised Controlled Trial.
Kien Hoa Ly1, Naira Topooco1, Hanna Cederlund1
1Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden.
Plos One
|May 27, 2015
Summary
A new blended depression treatment combining face-to-face sessions and a smartphone app showed significant improvements but was not proven non-inferior to full behavioral activation. This approach may double patient capacity, offering a potentially cost-effective alternative.
Area of Science:
- Clinical Psychology
- Digital Health
- Mental Health Treatment
Background:
- There is a critical need for more cost-effective and time-efficient depression treatments.
- This study introduces a novel blended treatment approach for major depression, integrating face-to-face sessions with a smartphone application.
- The trial registration number is NCT01819025.
Purpose of the Study:
- To investigate if a blended treatment (four face-to-face sessions + smartphone app) is non-inferior to a full behavioral activation (BA) treatment for depression.
- To assess the efficacy and potential cost-effectiveness of a smartphone-supported blended therapy model.
Main Methods:
- A randomized controlled non-inferiority trial comparing a blended treatment (n=46) against a full ten-session behavioral activation treatment (n=47).
- The primary outcome measure was the Beck Depression Inventory-II (BDI-II), assessed at pre-treatment, post-treatment, and six-month follow-up.
- Therapist time was recorded to evaluate efficiency.
Main Results:
- Both the blended and full BA treatment groups showed significant within-group improvements over time on the BDI-II.
- No statistically significant difference was found between the groups for the primary outcome measure, failing to establish non-inferiority.
- The blended treatment significantly reduced therapist time by an average of 47% compared to the full treatment.
Conclusions:
- While non-inferiority was not established, the blended treatment demonstrated significant symptom reduction and reduced therapist time.
- The smartphone-augmented approach has the potential to nearly double the number of depression patients treated, suggesting increased capacity.
- Further research is necessary to confirm the blended treatment as a promising, cost-effective alternative to traditional face-to-face therapy for depression.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

